LANXESS faces fresh downgrades. Lanxess stock gains 2.25 percent

Published on 10/16/2026 at 10:13 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Fair value fell from EUR 16.77 to EUR 15.41 on October 13, 2026. Lanxess stock costs EUR 12.72 on October 16, 2026, 2.25 percent above the Xetra close.

Analyst caution and November results

Modelled fair value fell from EUR 16.77 to EUR 15.41 on October 13, 2026.
Lanxess reported Q2 2026 revenue of EUR 1.56 billion and adjusted earnings per share of EUR 0.51.
Lanxess stock trades at EUR 12.72 at 10:06 a.m. CEST at Lang & Schwarz on October 16, 2026, 2.25 percent above the Xetra close of October 15, 2026.
LANXESS scheduled its Q3 2026 results for November 5, 2026.

Trading-Floor mit Börsenhändlern vor Bildschirmen mit Chemie-Sektor-Charts — Lanxess AG (DE0005470405) notiert an der Börse Frankfurt, dargestellt am Trading-Floor mit Chemie-Charts, Illustration mit AI erstellt.

Lanxess stock (ISIN DE0005470405) was trading at EUR 12.72 at Lang & Schwarz on October 16, 2026 at 10:06 a.m. CEST, up 2.25 percent versus the Xetra close of October 15, 2026 at EUR 12.44. A fresh round of analyst downgrades has put the chemicals group's earnings recovery and Envalior value contribution under scrutiny, as Yahoo Finance reported on October 13, 2026.

Three dates frame the reset

The recent sequence shows how the market debate has shifted. On August 7, 2026, Lanxess reported Q2 2026 revenue of EUR 1.56 billion and adjusted earnings per share of EUR 0.51, according to TickerLandia. On September 25, 2026, Jefferies cut its price target from EUR 14.00 to EUR 11.00 and retained an Underperform rating, citing cost pressure, according to Investing.com. On October 15, 2026, Simply Wall St described fresh downgrades from BNP Paribas and Berenberg and cited a fair value of EUR 15.41 against EUR 16.77 previously.

What does the target cut mean?

The central issue is not the latest intraday gain but the distance between the share price and the assumptions behind analyst models. The EUR 15.41 fair value cited by Simply Wall St stands 21.15 percent above the Lang & Schwarz price of EUR 12.72, while the same article identified Chinese competition and elevated European energy costs as risks to the recovery case. Berenberg cut its target from EUR 17.00 to EUR 13.80, according to Yahoo Finance.

November 5, 2026 sets next test

LANXESS lists November 5, 2026 for its Q3 2026 results and an investor-relations conference call at 1:00 p.m. CEST, according to the company's LANXESS investor page. The reporting date matters because Jefferies expects third-quarter EBITDA of EUR 134 million, below consensus of EUR 139 million, while its fiscal-year 2026 EBITDA forecast is EUR 482 million.

Stock gains while estimates reset

Lanxess remains a specialty chemicals company focused on chemical intermediates, additives and consumer protection products. Its 52-week range is EUR 11.03 to EUR 22.02 as of October 16, 2026, placing the current quote 15.33 percent above the low and 42.23 percent below the high. The combination of a positive intraday move and lower analyst assumptions leaves the November report as the next quantified test for the recovery narrative.

Current quote and reference

After the Xetra close of October 15, 2026 at EUR 12.44, Lanxess was trading at EUR 12.72 at Lang & Schwarz on October 16, 2026 at 10:06 a.m. CEST, a gain of 2.25 percent.

The further course of trading is shown by the continuously updated real-time quote of Lanxess stock.